A multicentre, ramdomised, open label phase 3 study comparing the efficacy and safety of once daily (O.D) ORG31540/SR90107A versus adjusted dose intravenous (I.V) unfractioned heparin (UFH) in the ini
- Salem, Hatem (Primary Chief Investigator (PCI))
Project: Research